Lupus Clinical Trials Consortium Katherine M Snider President is located in Garden City, NY. The organization was established in 2003. According to its NTEE Classification (H80) the organization is classified as: Specifically Named Diseases Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lupus Clinical Trials Consortium Katherine M Snider President is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Lupus Clinical Trials Consortium Katherine M Snider President generated $2.6m in total revenue. The organization has seen a slow decline revenue. Over the past 4 years, revenues have fallen by an average of (2.1%) each year. All expenses for the organization totaled $2.1m during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (2.5%) per year over the past 4 years. You can explore the organizations financials more deeply in the financial statements section below.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Katherine M Snider President And Trustee | 40 | $0 | |
Joseph E Craft MD Secretary And Trustee | 3 | $0 | |
Bevra H Hahn MD Trustee | 1 | $0 | |
Matthew H Liang MD MPH Trustee | 2.5 | $0 | |
David S Pisetsky MD PHD Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Northstudio Ltd | 12/30/22 | $937,833 |
Akamai Technologies Inc | 12/30/22 | $248,400 |
Ropes And Gray Llp | 12/30/22 | $217,825 |
Amoeba Network | 12/30/22 | $175,208 |
Immaus Technology Solutions Llc | 12/30/22 | $104,650 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $2,572,271 |
Interest on Savings | $71 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $2,572,342 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $47 |
Taxes | $1 |
Depreciation | $20,477 |
Occupancy | $0 |
Travel, conferences, and meetings | $7,702 |
Printing and publications | $0 |
Other expenses | $483,648 |
Total operating and administrative expenses | $2,078,146 |
Contributions, gifts, grants paid | $0 |
Total expenses and disbursements | $2,078,146 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $687,326 |
Savings and temporary cash investments | $217,020 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $44,405 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $10,234 |
Other assets | $0 |
Total assets | $958,985 |
Accounts payable and accrued expenses | $370,521 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $59 |
Total liabilities | $370,580 |